Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Healthcare Services Industry Analysis

UpdatedApr 16, 2026
DataAggregated Company Financials
Companies102
  • 7D-2.7%
  • 3M-5.5%
  • 1Y-0.3%
  • YTDn/a

Over the last 7 days, the Healthcare Services industry has dropped 2.7%, driven by a pullback from CVS Health of 4.8%. In contrast, Hims & Hers Health has gained 25%. Over the last year, the industry has been flat overall. Earnings are forecast to grow by 20% annually.

Industry Valuation and Performance

Has the U.S. Healthcare Services Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 16 Apr 2026US$292.9bUS$774.9bUS$9.9b29.1x29.6x0.4x
Sat, 14 Mar 2026US$286.3bUS$772.5bUS$9.7b25.5x29.4x0.4x
Mon, 09 Feb 2026US$300.0bUS$763.1bUS$8.3b26.9x36x0.4x
Wed, 07 Jan 2026US$302.3bUS$755.9bUS$8.6b26.1x35.3x0.4x
Fri, 05 Dec 2025US$293.1bUS$754.8bUS$8.6b29.2x34.2x0.4x
Sun, 02 Nov 2025US$283.2bUS$754.4bUS$8.5b31.9x33.4x0.4x
Tue, 30 Sep 2025US$299.2bUS$740.1bUS$11.4b25.8x26.3x0.4x
Thu, 28 Aug 2025US$296.0bUS$740.0bUS$11.3b24x26.2x0.4x
Sat, 26 Jul 2025US$273.7bUS$727.9bUS$12.5b23.9x21.8x0.4x
Mon, 23 Jun 2025US$293.4bUS$727.3bUS$12.5b25.9x23.6x0.4x
Wed, 21 May 2025US$288.8bUS$726.6bUS$12.2b25.6x23.7x0.4x
Fri, 18 Apr 2025US$286.5bUS$710.2bUS$9.7b27.1x29.4x0.4x
Sun, 16 Mar 2025US$282.6bUS$710.3bUS$9.5b29x29.9x0.4x
Tue, 11 Feb 2025US$269.1bUS$704.7bUS$9.5b27.4x28.3x0.4x
Thu, 09 Jan 2025US$249.1bUS$686.7bUS$8.8b26x28.4x0.4x
Sat, 07 Dec 2024US$278.9bUS$686.8bUS$7.9b29.1x35.4x0.4x
Mon, 04 Nov 2024US$274.8bUS$683.0bUS$10.1b33.4x27.3x0.4x
Wed, 02 Oct 2024US$296.4bUS$667.7bUS$10.6b32x27.9x0.4x
Fri, 30 Aug 2024US$289.3bUS$667.5bUS$10.5b32.3x27.4x0.4x
Sun, 28 Jul 2024US$292.3bUS$656.3bUS$10.5b30.8x27.8x0.4x
Tue, 25 Jun 2024US$282.2bUS$654.3bUS$10.2b29.1x27.7x0.4x
Thu, 23 May 2024US$277.3bUS$654.3bUS$10.3b26.8x26.8x0.4x
Sat, 20 Apr 2024US$293.8bUS$642.9bUS$11.7b29.9x25.1x0.5x
Mon, 18 Mar 2024US$309.2bUS$643.1bUS$12.2b35.9x25.4x0.5x
Wed, 14 Feb 2024US$304.4bUS$644.9bUS$13.3b33.5x22.8x0.5x
Fri, 12 Jan 2024US$320.1bUS$625.8bUS$13.8b34.6x23.2x0.5x
Sun, 10 Dec 2023US$298.7bUS$625.7bUS$13.7b33.3x21.8x0.5x
Tue, 07 Nov 2023US$312.9bUS$624.9bUS$13.1b25.3x23.9x0.5x
Thu, 05 Oct 2023US$302.5bUS$612.2bUS$8.8b28.5x34.5x0.5x
Sat, 02 Sep 2023US$303.2bUS$610.7bUS$8.6b28x35.1x0.5x
Mon, 31 Jul 2023US$321.4bUS$598.2bUS$10.4b27.2x31x0.5x
Wed, 28 Jun 2023US$310.4bUS$598.0bUS$10.1b28x30.7x0.5x
Fri, 26 May 2023US$299.8bUS$598.1bUS$10.1b25.3x29.7x0.5x
Sun, 23 Apr 2023US$310.6bUS$586.9bUS$10.9b22.5x28.4x0.5x
Price to Earnings Ratio

28.4x


Total Market Cap: US$310.6bTotal Earnings: US$10.9bTotal Revenue: US$586.9bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthcare Services Industry Price to Earnings3Y Average 28.7x202420252026
Current Industry PE
  • Investors are relatively neutral on the American Healthcare Services industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 28.7x.
  • The industry is trading close to its 3-year average PS ratio of 0.44x.
Past Earnings Growth
  • The earnings for companies in the Healthcare Services industry have declined 3.3% per year over the last three years.
  • Meanwhile revenues for these companies have grown 9.7% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does U.S. Healthcare Services compare with similar industries?

US Market3.42%
Healthcare-0.18%
Healthcare Services-0.58%
Healthcare Services-2.74%
Managed Healthcare1.48%
Healthcare Distributors-1.60%
Healthcare Facilities-2.19%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
HIMS Hims & Hers HealthUS$24.2925.3%
+US$1.1b		-9.9%PE43.1x
HNGE Hinge HealthUS$41.478.3%
+US$250.5m		n/aPS5.6x
RDNT RadNetUS$58.224.1%
+US$179.3m		15.2%PS2.2x
AGL agilon healthUS$26.8845.5%
+US$139.6m		-80.3%PS0.08x
CRVL CorVelUS$55.964.4%
+US$121.2m		-52.2%PE27.1x

Latest News

LH
US$266.73
Labcorp Holdings
7D
-2.9%
1Y
20.9%
CVS
US$74.99
CVS Health
7D
-4.8%
1Y
9.4%
BLLN
US$80.61
BillionToOne
7D
-12.4%
1Y
n/a
AGL
US$26.88
agilon health
7D
45.5%
1Y
-80.3%
HIMS
US$24.29
Hims & Hers Health
7D
25.3%
1Y
-9.9%
GH
US$84.86
Guardant Health
7D
-8.6%
1Y
87.8%
DVA
US$144.57
DaVita
7D
-2.6%
1Y
2.2%

DaVita: Further Upside Is Trickier (Rating Downgrade)

Apr 11
PRVA
US$23.44
Privia Health Group
7D
3.2%
1Y
-1.8%

PRVA: Payor Agnostic Enablement And Collections Timing Execution Will Support EBITDA

Privia Health Group's updated fair value estimate edges to $31.75 from $31.95 as analysts balance slightly softer embedded revenue growth assumptions with a modestly higher profit margin outlook and a similar future P/E profile, following a mix of recent price target raises and cuts across the Street. Analyst Commentary Recent Street research around Privia Health Group shows a mixed but generally constructive tone, with several price target raises offset by a couple of modest trims.
CHE
US$377.61
Chemed
7D
-4.5%
1Y
-35.0%

CHE: Expanded Buybacks And Earnings Guidance Will Support Stronger Future Returns

Analysts have kept their price target for Chemed steady at $443. This reflects updated assumptions around slightly different revenue growth, profit margin and future P/E inputs that do not materially change their overall valuation view.
RDNT
US$58.22
RadNet
7D
4.1%
1Y
15.2%

RDNT: Outpatient Imaging Shift Will Support Future Earnings Visibility

RadNet's analyst price target now stands at $92. Analysts cite outpatient diagnostic imaging growth drivers, Medicare reimbursement support, potential capital deployment, and an AI ramp as key reasons for maintaining this level.
ASTH
US$29.23
Astrana Health
7D
6.6%
1Y
-10.6%

Astrana Health: A Delegated Risk Model At A Discount

Apr 08
DGX
US$191.42
Quest Diagnostics
7D
-3.7%
1Y
16.4%
MD
US$22.19
Pediatrix Medical Group
7D
3.8%
1Y
68.9%

MD: Future Earnings Upside Will Be Driven By Expansion And Buybacks

Analysts have kept their Pediatrix Medical Group price target steady at $24.00, noting only small adjustments in revenue growth, profit margin assumptions, and expected future P/E that offset each other in their updated models. What's in the News Pediatrix Medical Group expanded in Middle Tennessee through a partnership with Tennessee Maternal-Fetal Medicine, rebranding the practice as Maternal-Fetal Medicine Specialists of Tennessee under the Pediatrix banner and maintaining five locations across Greater Nashville.
HNGE
US$41.47
Hinge Health
7D
8.3%
1Y
n/a
CI
US$268.63
Cigna Group
7D
-3.2%
1Y
-18.5%

CI: Leadership Transition And Onsite Care Expansion Will Drive Future Upside

Analysts have slightly refined their view on Cigna Group, trimming the price target by a fraction to $338.79 as updated assumptions for revenue growth, profit margins, and future P/E bring the model into closer alignment with their latest expectations. What's in the News Cigna Group plans a leadership transition, with David M.
CRVL
US$55.96
CorVel
7D
4.4%
1Y
-52.2%